Product Specifications for Recombinant Human KIR2DL4/CD158d Fc Chimera Protein, CF
Mouse myeloma cell line, NS0-derived human KIR2DL4/CD158d protein
Human KIR2DL4 (His24 - His242) Accession # Q99706
Human IgG1 (Pro100 - Lys330)
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal sequence Analysis
Predicted Molecular Mass
24.4 kDa (monomer)
65 kDa, reducing conditions
Measured by its ability to inhibit anti-KIR2DL4 antibody induced IFN-gamma secretion by NK‑92 human natural killer lymphoma cells. The ED50 for this effect is 0.3-1 µg/mL in the presence of 1 µg/mL of immobilized mouse anti-hKIR2DL4 antibody (Catalog # MAB2238).
Formulation, Preparation and Storage
What does CF mean?
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our
Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant
protein to be stored at a more dilute concentration.
The carrier free version does not contain BSA.
What formulation is right for me?
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or
as an ELISA standard.
In contrast, the carrier free protein is recommended for applications, in which the presence of BSA
Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitute at 100 μg/mL in sterile PBS.
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
KIR2DL4 (also known as 2DL4, p49, CD158d, KIR103) is a type I transmembrane protein of the killer cell Ig-like receptor (KIR) family expressed on NK and subsets of gamma δT and memory/effector alpha beta T cells. KIR2DL4 is a unique KIR (1 - 3); alleles are not clonally restricted but are expressed codominantly (4) in all activated NK cells and constitutively on CD56hi NK cells. KIR members with two Ig-like domains (2D) usually express domains D1 and D2, but KIR2DL4 expresses D0 and D2. Other long-tailed (L) KIR have two cytoplasmic inhibitory signaling domains (ITIM), but KIR2DL4 has one ITIM and also exhibits characteristics of activating KIR (2). An arginine within the transmembrane sequence of KIR2DL4 interacts with the signaling molecule Fc epsilon RI-gamma, while in activating KIR, a transmembrane lysine interacts with DAP12 (1, 5). The KIR2DL4 gene is highly polymorphic. Seven splice variants missing one or more exons have been identified, but it is not clear whether these are expressed. Several of the nine alleles identified encode a frameshift creating a prematurely truncated protein. It is estimated that up to 25% of humans do not express KIR2DL4 capable of reaching the cell surface (1, 7, 10). Human KIR2DL4 is 65 - 83% amino acid identical to other primates. KIR receptors have no structural orthologs in non-primates, although mouse Ly49 proteins are functional orthologs. Cross-linking of KIR2DL4 induces NK cells to produce IFN-gamma (6, 7); stimulation with IL-2 upregulates cell surface expression on CD56dim cells and allows cytotoxicity (7). Although a role in immune privilege of the fetus has been suggested due to reported recognition of fetal trophoblast HLA-G by KIR2DL4 in the maternal decidua (11), subsequent data have not supported this recognition (1, 9).
Lanier, L.L. (2005) Annu. Rev. Immunol. 23:225.
Faure, M. and E.O. Long (2002) J. Immunol. 168:6208.
Selvakumar, A. et al. (1996) Tissue Antigens 48:285.
Chan, H.-W. et al. (2003) J. Exp. Med. 197:245.
Kikuchi-Maki, A. et al. (2005) J. Immunol. 174:3859.
Rajagopalan, S. et al. (2001) J. Immunol. 167:1877.
Kikuchi-Maki, A. et al. (2003) J. Immunol. 171:3415.
Gedil, M.A. et al. (2005) Tissue Antigens 65:402.
Witt, C.S. et al. (2002) Eur. J. Immunol. 32:18.
Goodridge, J.P. et al. (2003) J. Immunol. 171:1768.
Ponte, M. et al. (1999) Proc. Natl. Acad. Sci. USA 96:5674.
Killer Cell Immunoglobulin-like Receptor, Two Domain Long Cytoplasmic Tail, 4
Entrez Gene IDs
103AS, 15.212, CD158 antigen-like family member D, CD158DKIR103ASKiller cell inhibitory receptor 103AS, CD158d, CD158d antigen, G9P, KIR-103AS, KIR103, KIR2DL4, MHC class I NK cell receptor KIR103AS, NK cell receptor, killer Ig receptor, killer cell immunoglobulin-like receptor 2DL4, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, natural killer cell inhibitory receptor
Which Brands are Currently Available on bio‑techne.com? R&D Systems, Tocris Bioscience and ProteinSimple branded products are available to purchase through bio‑techne.com. ProteinSimple branded instruments are available to quote. ACD branded products will be available on bio‑techne.com in the near future. Novus Biologicals branded products are not currently available on bio‑techne.com and can be found at novusbio.com.
Setting the standard in quality research reagents for over 30 years
A trusted leader in quality life science reagents
Your trusted supplier for innovative and high performance life science reagents
Proprietary systems and consumables for simpler, more quantitative and affordable protein analysis
Proprietary RNAscope® technology capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity
A world leader in developing liquid biopsy based diagnostics